SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001564590-19-041513
Filing Date
2019-11-07
Accepted
2019-11-07 12:39:16
Documents
3
Period of Report
2019-11-07
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K 9/30/19 FINANCIAL PRESS RELEASE apvo-8k_20191107.htm 8-K 33300
2 EX-99.1 apvo-ex991_6.htm EX-99.1 327041
3 GRAPHIC gcsbjcnlfdmd000001.jpg GRAPHIC 2623
  Complete submission text file 0001564590-19-041513.txt   365237
Mailing Address 2401 4TH AVE. SUITE 1050 SEATTLE WA 98121
Business Address 2401 4TH AVE. SUITE 1050 SEATTLE WA 98121 206-838-0500
Aptevo Therapeutics Inc. (Filer) CIK: 0001671584 (see all company filings)

IRS No.: 811567056 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37746 | Film No.: 191199290
SIC: 2834 Pharmaceutical Preparations